yamahalion posts 48/F HSIL Pap smear

A Pap smear is a screening test that looks at cervical cells under a microscope for early changes that can turn into cancer. In a case posted by pathologist @yamahalion, the reported result was high-grade squamous intraepithelial lesion, or HSIL, in a 48-year-old woman. (cancer.gov) (acog.org) HSIL is the label used when the abnormal cells look more serious than low-grade changes and are more strongly linked to precancer. The American College of Obstetricians and Gynecologists says HSIL is more likely than low-grade squamous intraepithelial lesion, or LSIL, to be tied to precancer and cancer. (acog.org) Under the microscope, HSIL cells are typically small with relatively little cytoplasm and enlarged, dark, irregular nuclei. Pathology Outlines describes the pattern as a high nuclear-to-cytoplasmic ratio with nuclear enlargement, hyperchromasia, and irregular contours or grooves. (pathologyoutlines.com) That microscopic pattern matters because Pap testing is meant to catch cell changes before invasive cancer develops. The National Cancer Institute says most people with abnormal cervical screening results do not have cancer, but abnormal findings need the follow-up their clinician recommends. (cancer.gov) Human papillomavirus, or HPV, drives most of these abnormalities. ACOG says most cervical cancer cases are caused by high-risk HPV types, especially types 16 and 18, and Pathology Outlines says virtually all HSIL cytology cases are positive for high-risk HPV. (acog.org) (pathologyoutlines.com) A Pap result by itself is not the final diagnosis. ACOG says an abnormal Pap test or positive HPV test can lead to follow-up testing, and the National Cancer Institute lists colposcopy and biopsy among the next-step procedures used after abnormal screening. (acog.org) (cancer.gov) U.S. management guidelines treat HSIL as one of the highest-risk screening categories. The 2019 American Society for Colposcopy and Cervical Pathology guidelines say that for some nonpregnant patients 25 or older, treatment without a prior biopsy can be preferred when the immediate risk of severe precancer is high enough. (asccp.org) (pmc.ncbi.nlm.nih.gov) The online post turned a single slide into a public teaching session about how cytologists separate HSIL from lookalikes such as atrophy, metaplasia, and other benign or borderline changes. That is the core task of cervical cytology: finding the small group of abnormal cells that changes what happens next for the patient. (pathologyoutlines.com)